Kranjcevic J, conkas J, Ozretic P
Cancers (Basel). 2024; 16(8).
PMID: 38672656
PMC: 11049451.
DOI: 10.3390/cancers16081575.
conkas J, Sabol M, Ozretic P
Int J Mol Sci. 2023; 24(4).
PMID: 36835177
PMC: 9965076.
DOI: 10.3390/ijms24043766.
Horwitz K, Sartorius C
J Mol Endocrinol. 2020; 65(1):T49-T63.
PMID: 32485679
PMC: 8525510.
DOI: 10.1530/JME-20-0104.
Dou X, Tong P, Huang H, Zellmer L, He Y, Jia Q
J Cancer. 2020; 11(10):2887-2920.
PMID: 32226506
PMC: 7086263.
DOI: 10.7150/jca.41324.
Silva T, Moretto F, de Sibio M, Goncalves B, Oliveira M, Olimpio R
Arch Endocrinol Metab. 2019; 63(2):142-147.
PMID: 30916164
PMC: 10522138.
DOI: 10.20945/2359-3997000000114.
Spontaneous Cancers, But Not Many Induced Ones in Animals, Resemble Semi-New Organisms that Possess a Unique Programmed Cell Death Mode Different from Apoptosis, Senescent Death, Necrosis and Stress-Induced Cell Death.
Shi M, Zhou H, Lei M, Chen L, Zellmer L, He Y
J Cancer. 2018; 9(24):4726-4735.
PMID: 30588258
PMC: 6299389.
DOI: 10.7150/jca.26502.
While it is not deliberate, much of today's biomedical research contains logical and technical flaws, showing a need for corrective action.
He Y, Yuan C, Chen L, Liu Y, Zhou H, Xu N
Int J Med Sci. 2018; 15(4):309-322.
PMID: 29511367
PMC: 5835702.
DOI: 10.7150/ijms.23215.
Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others.
Bartlett J, Bayani J, Marshall A, Dunn J, Campbell A, Cunningham C
J Natl Cancer Inst. 2016; 108(9).
PMID: 27130929
PMC: 5939629.
DOI: 10.1093/jnci/djw050.
Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology.
Wang C, Lisanti M, Liao D
Cell Cycle. 2011; 10(1):57-67.
PMID: 21200143
PMC: 3048075.
DOI: 10.4161/cc.10.1.14449.
Effect of the anti-oestrogen tamoxifen on the development of renal cortical necrosis induced by oestrone + vasopressin administration in rats.
Kocsis J, Karacsony G, Karcsu S, Laszlo F
Br J Exp Pathol. 1988; 69(2):157-67.
PMID: 3377960
PMC: 2013217.
Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study.
HEUSON J, ENGELSMAN E, Maass H, DROCHMANS A, Michel J, NOWAKOWSKI H
Br Med J. 1975; 2(5973):711-3.
PMID: 1095121
PMC: 1673940.
DOI: 10.1136/bmj.2.5973.711.
Multiple steroid receptors in human breast cancer. III. Relationships between steroid receptors and the state of differentiation and the activity of carcinomas throughout the pathologic features.
Martin P, Rolland P, Jacquemier J, Rolland A, TOGA M
Cancer Chemother Pharmacol. 1979; 2(2):115-20.
PMID: 535122
DOI: 10.1007/BF00254083.
Multiple steroid receptors in human breast cancer. II. Estrogen and progestin receptors in 672 primary tumors.
Martin P, Rolland P, Jacquemier J, Rolland A, TOGA M
Cancer Chemother Pharmacol. 1979; 2(2):107-13.
PMID: 535121
DOI: 10.1007/BF00254082.
Histopathogenesis of 7,12-diemthylbenz(a)anthracene-induced rat mammary tumors.
Haslam S, Bern H
Proc Natl Acad Sci U S A. 1977; 74(9):4020-4.
PMID: 410031
PMC: 431827.
DOI: 10.1073/pnas.74.9.4020.
Effect of different sex of tumour bearing mice and of ovariectomy on the proliferation kinetics of a solid, transplantable mammary carcinoma (C3H-mouse).
Feaux de Lacroix W, Hensen F, Klein P, Nola E, LENNARTZ K
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1976; 87(2):181-91.
PMID: 136825
DOI: 10.1007/BF00284375.
